HCWB
HCWB
NASDAQ · Biotechnology

Hcw Biologics Inc

$0.40
+0.03 (+6.92%)
As of Mar 29, 11:04 PM ET ·
Financial Highlights (FY 2026)
Revenue
14.25M
Net Income
-166,699,875
Gross Margin
37.4%
Profit Margin
-1,169.7%
Rev Growth
D/E Ratio
0.47
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 37.4% 30.6% 30.6% 30.6%
Operating Margin -1,148.5% -4.3% -4.2% -3.9%
Profit Margin -1,169.7% -5.3% -5.3% -5.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 14.25M 491.6K 478.0K 424.9K
Gross Profit 5.33M 150.3K 146.1K 129.9K
Operating Income -163,675,801 -21,141 -20,310 -16,746
Net Income -166,699,875 -25,839 -25,168 -22,690
Gross Margin 37.4% 30.6% 30.6% 30.6%
Operating Margin -1,148.5% -4.3% -4.2% -3.9%
Profit Margin -1,169.7% -5.3% -5.3% -5.3%
Rev Growth +16.5% +3.1% +2.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 342.5K 313.4K 286.1K 295.5K
Total Equity 731.4K 2.43M 2.68M 2.44M
D/E Ratio 0.47 0.13 0.11 0.12
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -161,654,369 -32,660 -28,783 -26,607
Free Cash Flow -24,331 -23,138 -19,951